SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-009697
Filing Date
2024-03-28
Accepted
2024-03-28 08:36:06
Documents
19
Period of Report
2024-03-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K crvo20240326_8k.htm   iXBRL 8-K 46151
2 EXHIBIT 4.1 ex_645158.htm EX-4.1 90449
3 EXHIBIT 4.2 ex_646585.htm EX-4.2 234819
4 EXHIBIT 10.1 ex_646646.htm EX-10.1 357321
5 EXHIBIT 99.1 ex_646647.htm EX-99.1 13121
10 logomed.jpg GRAPHIC 5516
  Complete submission text file 0001437749-24-009697.txt   1039486

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA crvo-20240328.xsd EX-101.SCH 3410
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20240328_def.xml EX-101.DEF 11425
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20240328_lab.xml EX-101.LAB 15311
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20240328_pre.xml EX-101.PRE 11585
22 EXTRACTED XBRL INSTANCE DOCUMENT crvo20240326_8k_htm.xml XML 2820
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 24793718
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)